Astrazeneca PLC (AZN): Price and Financial Metrics

Astrazeneca PLC (AZN): $61.77

-0.02 (-0.03%)

POWR Rating

Component Grades














  • AZN scores best on the Growth dimension, with a Growth rank ahead of 84.95% of US stocks.
  • The strongest trend for AZN is in Momentum, which has been heading down over the past 52 weeks.
  • AZN ranks lowest in Momentum; there it ranks in the 18th percentile.

AZN Stock Summary

  • Astrazeneca Plc's market capitalization of $160,641,280,000 is ahead of 98.56% of US-listed equities.
  • AZN's current price/earnings ratio is 42.63, which is higher than 78.07% of US stocks with positive earnings.
  • With a year-over-year growth in debt of 39.24%, Astrazeneca Plc's debt growth rate surpasses 84.04% of about US stocks.
  • Stocks that are quantitatively similar to AZN, based on their financial statements, market capitalization, and price volatility, are SAP, NVS, ABBV, RTX, and SNY.
  • Visit AZN's SEC page to see the company's official filings. To visit the company's web site, go to

AZN Valuation Summary

  • AZN's EV/EBIT ratio is 29.1; this is 0.68% lower than that of the median Healthcare stock.
  • Over the past 243 months, AZN's price/sales ratio has gone up 2.7.
  • Over the past 243 months, AZN's price/sales ratio has gone up 2.7.

Below are key valuation metrics over time for AZN.

Stock Date P/S P/B P/E EV/EBIT
AZN 2021-08-31 5.2 9.8 40.6 29.1
AZN 2021-08-30 5.2 9.8 40.8 29.2
AZN 2021-08-27 5.2 9.8 40.8 29.3
AZN 2021-08-26 5.2 9.8 40.9 29.3
AZN 2021-08-25 5.2 9.8 40.8 29.2
AZN 2021-08-24 5.2 9.8 40.8 29.2

AZN Growth Metrics

  • Its year over year cash and equivalents growth rate is now at 123.73%.
  • Its 2 year net income to common stockholders growth rate is now at -47.08%.
  • The 4 year net income to common stockholders growth rate now stands at -51.22%.
AZN's revenue has moved up $7,186,000,000 over the prior 37 months.

The table below shows AZN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 29,528 6,446 3,768
2021-03-31 27,583 6,594 3,956
2020-12-31 26,617 4,799 3,144
2020-09-30 25,871 4,376 2,416
2020-06-30 25,699 3,657 2,045
2020-03-31 25,247 3,495 1,414

AZN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AZN has a Quality Grade of B, ranking ahead of 78.06% of graded US stocks.
  • AZN's asset turnover comes in at 0.438 -- ranking 106th of 681 Pharmaceutical Products stocks.
  • CLVS, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with AZN.

The table below shows AZN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.438 0.765 0.209
2021-03-31 0.431 0.792 0.231
2020-12-31 0.429 0.801 0.205
2020-09-30 0.427 0.801 0.174
2020-06-30 0.433 0.800 0.161
2020-03-31 0.422 0.794 0.126

AZN Stock Price Chart Interactive Chart >

Price chart for AZN

AZN Price/Volume Stats

Current price $61.77 52-week high $62.06
Prev. close $61.79 52-week low $46.48
Day low $61.33 Volume 3,144,700
Day high $61.96 Avg. volume 9,366,036
50-day MA $59.03 Dividend yield 2.22%
200-day MA $55.11 Market Cap 191.38B

Astrazeneca PLC (AZN) Company Bio

AstraZeneca plc engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. The company was founded in 1992 and is based in London, the United Kingdom.

AZN Latest News Stream

Event/Time News Detail
Loading, please wait...

AZN Latest Social Stream

Loading social stream, please wait...

View Full AZN Social Stream

Latest AZN News From Around the Web

Below are the latest news stories about Astrazeneca Plc that investors may wish to consider to help them evaluate AZN as an investment opportunity.

'We're definitely not doing enough' to help global vaccinations: Former US Commerce Sec.

Former U.S. Commerce Sec. Gary Locke weighs in on the global vaccine equity debate and how the U.S. can better respond to the ongoing pandemic.

Yahoo | October 22, 2021

COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection

Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of Medicine on Wednesday, tracked nearly 18,500 pregnant women in Norway, including about 4,500 who had miscarriages. Researchers found no link between COVID-19 vaccines and risk of first-trimester miscarriage, regardless of whether the vaccines were from Moderna, Pfizer and BioNTech, or AstraZeneca.

Yahoo | October 22, 2021

Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG

Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

Yahoo | October 22, 2021

With EPS Growth And More, AstraZeneca (LON:AZN) Is Interesting

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Yahoo | October 22, 2021

7 Penny Stocks to Buy to Sidestep the Noise on Wall Street

With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar.

Josh Enomoto on InvestorPlace | October 21, 2021

Read More 'AZN' Stories Here

AZN Price Returns

1-mo 2.35%
3-mo 9.58%
6-mo 21.19%
1-year 19.52%
3-year 77.68%
5-year 157.00%
YTD 26.89%
2020 3.06%
2019 35.58%
2018 13.77%
2017 33.10%
2016 -15.90%

AZN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AZN Dividend History

Continue Researching AZN

Here are a few links from around the web to help you further your research on Astrazeneca Plc's stock as an investment opportunity:

Astrazeneca Plc (AZN) Stock Price | Nasdaq
Astrazeneca Plc (AZN) Stock Quote, History and News - Yahoo Finance
Astrazeneca Plc (AZN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8765 seconds.